The Seoul National University Hospital (SNUH) said Monday its research team has found that the keyhole approach is safe and effective for multiple unruptured intracranial aneurysms (UIAs), offering a new paradigm for cerebral aneurysm treatment.The research team, led by Professor Cho Won-sang at the
Researchers at Gangnam Severance Hospital said Monday that they have found ways to predict sarcopenia using alkaline phosphatase (ALP), expecting it would become a new biomarker to predict and prevent muscle loss. Sarcopenia or muscle loss weakens bodily functions and causes medical complications li
A joint research team has succeeded in identifying the human development process using whole-genome sequencing technology, Kyungpook National University Hospital (KNUH) said Friday.The study was published in the online edition of Nature on Aug. 25.Professor Oh Ji-won of Kyungpook National University
Kymriah, the second-line treatment of Novartis for lymphoma, has suffered a setback in the phase 3 BVELINDA clinical study to confirm its efficacy by failing to meet the primary endpoint.On Wednesday (local time), Novartis released its updates on the BELINDA study of Kymriah on patients who had rela
As the fourth wave of the Covid-19 pandemic prolongs, calls are mounting for “overcoming the limitation of K-quarantine.” In a joint emergency statement, the Korean Society for Preventive Medicine (KSPM) and the Korean Society of Epidemiology (KSEPI) said the country should prepare for “sustainable
The Korea National Enterprise for Clinical Trials (KONECT) said Wednesday that it has agreed with SK Bioscience to help recruit phase 3 clinical trial participants for the first Korean-made Covid-19 vaccine.Under the agreement, the two sides will share the information on the agency and research team
GenNBio said Wednesday it has submitted an investigational new drug (IND) application to conduct the phase 1 trial of the xenotransplantation of germ-free pigs’ Langerhans islets to diabetes patients to the Ministry of Food and Drug Safety.In August last year, GenNBio applied for IND to conduct an i
VUNO Med®–DeepCARS™, AI-based cardiac arrest prediction software, has won approval from the Ministry of Food and Drug Safety, the company said Tuesday.Vuno said its UNO Med®–DeepCARS™ predicts the risk of cardiac arrest based on vital signs like blood pressure, pulse rate, respiratory rate, and body
Daratumumab, new targeted cancer therapy for multiple myeloma, could reactivate the hepatitis B virus, Seoul St. Mary’s Hospital said Tuesday.I was the first such finding in the world, the hospital added.A research team studied 105 multiple myeloma patients who went through Daratumumab treatment fro
Samsung Medical Center (SMC) said Tuesday that the hospital has conducted the largest number of abdominal aortic aneurysm repairs on Marfan syndrome (MFS) patients in the world.MFS is a congenital connective tissue disease that affects the cardiovascular system. It can cause fatal complications like
Amivantamab, approved by the U.S. FDA as the first targeted treatment for non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) Exon 20 insertion (Exon20ins) mutations in May, has proved its efficacy.EGFR Exon20ins mutations are known to show inherent resistance to tyrosine
Abion revealed its growth strategies and future plans in an online news conference on Monday ahead of its upcoming IPO in the Kosdaq market. “With our differentiated R&D strategies, Abion will achieve technology transfers through continuous studies,” CEO Shin Young-key said. “By going public on the
Celltrion signed the contract to acquire the exclusive sales rights of Donerion Patch, a donepezil patch product to treat the Alzheimer’s, which the company has co-developed with Icure, on Friday.Celltrion has submitted a new drug application for the drug to the Ministry of Food and Drug Safety for
Humedix said it agreed with HLB Pharma on the exclusive license use and joint research and development concerning long-acting injections for obesity treatment at its headquarters in Pangyo, Gyeonggi Province, on Wednesday.The agreement was the developed version of their memorandum of understanding s
GC Lab Cell said Thursday that it has won the Ministry of Food and Drug Safety’s approval for phase 1 clinical trial of CT303, a candidate substance of stem cell therapy for psoriasis.The company submitted an investigational new drug (IND) application for the trial in June.The trial is designed to a
The Seoul National University Hospital said Wednesday that sleep apnea patients need to consider conducting self-checks of their conditions at home amid the prolonged Covid-19 pandemic.“In Covid-19, people are hesitant to take polysomnography (PSG) that makes patients sleep outside the home to monit
North Korea has conducted Covid-19 tests on about 36,000 people but reported no confirmed cases so far, the World Health Organization said Wednesday in its COVID-19 Weekly Situation Report.According to the report, 35,947 North Koreans underwent the reverse transcription-polymerase chain reaction (RT
Systemic sclerosis (SSc) patients suffering from skin stiffening and organ disfunction should guard against the occurrence of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis in case they had found ANCAs through previous checks, researchers said Tuesday.Professor Lee Sang-won and Doc
Scioto Biosciences, a subsidiary of immuno-oncology firm Genome & Company, said it has completed the first administering of SB-121, a microbiome treatment for autism, on patients in the United States.“We moved a step forward to developing the first-in-class drug for autism treatment,” Genome & Compa
PharmaResearch said it held a symposium to launch its new regenerative medical device, Rejuran, with its Chinese partner Yxintent, in Urumqi, Xinjiang Autonomous Region, on Wednesday last week.At the symposium, Ok Seul-ong, a senior researcher at PharmaResearch, and Dr. Kim Soo-rim of TATOA China in